Bolt Biotherapeutics, Inc. (BOLT) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Bolt Biotherapeutics, Inc. (BOLT) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

BOLT Cash Flow Statement

Bolt Biotherapeutics, Inc. (BOLT) cash flow statement — 8-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-6.54M	-8.02M	-7.16M	-9.73M	-9.6M	-13.37M	-14.43M	-13.97M	-16.14M	-16.75M	-14.27M	-16.75M	-15.11M	-23.4M	-17.95M	-13.45M	-20.79M	-24.31M	-17.79M	-18.73M
Operating CF Margin %	-130800%	-30857.69%	-286.24%	-448.69%	-531.98%	-1093.7%	-	-1224.01%	-1266.04%	-317.61%	-682.86%	-662.54%	-1054.57%	-1281.43%	-1272.29%	-636.88%	-1492.25%	-2990.65%	-3502.76%	-2490.29%
Operating CF Growth %	31.85%	39.97%	50.41%	30.32%	40.55%	20.21%	-1.16%	16.62%	-6.82%	28.41%	20.54%	-24.52%	27.3%	3.76%	-0.89%	28.17%	-421.5%	-46.83%	-38.05%	-49.64%
Net Income	-7.72M	-7.24M	-6.63M	-7.14M	-8.56M	-11.04M	-15.94M	-15.18M	-21.2M	-10.81M	-17.9M	-16.26M	-18.06M	-16.98M	-20M	-21.76M	-22.66M	-23.68M	-27.16M	-23.39M
Depreciation & Amortization	171K	203K	255K	290K	347K	399K	426K	440K	457K	458K	467K	462K	458K	467K	462K	439K	408K	357K	361K	304K
Stock-Based Compensation	552K	545K	1.04M	407K	625K	709K	1.18M	1.1M	2.83M	2.3M	2.07M	2.33M	2.35M	2.48M	2.12M	2.14M	2.39M	2.92M	2.14M	2.23M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	-1.33M	0	0	0	0	0	0	0	0
Other Non-Cash Items	1.04M	590K	490K	506K	454K	118K	1.09M	250K	-3K	-260K	-436K	744K	-381K	-133K	234K	644K	894K	1.64M	1.47M	1.58M
Working Capital Changes	-582K	-2.12M	-2.31M	-3.79M	-2.46M	-3.55M	-1.2M	-578K	1.77M	-8.44M	1.54M	-2.69M	518K	-9.23M	-774K	5.08M	-1.82M	-5.55M	5.39M	555K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	200K	0	0	0	0	0	0	0	0	0	0	0	0	-6.61M	8.25M	0	-3.09M	0	0	0
Cash from Investing	7.77M	7.92M	1.07M	17.88M	10.79M	14.55M	12.23M	17.14M	18M	10.2M	15.81M	12.66M	13.58M	28.99M	16.43M	1.45M	-868K	40.84M	21.03M	-16.11M
Capital Expenditures	-13K	0	0	-72K	0	0	0	-41K	0	0	-6K	-165K	-32K	-3K	-184K	-735K	-429K	-605K	-562K	-1.01M
CapEx % of Revenue	260%	-	-	3.32%	-	-	-	3.59%	-	-	0.29%	6.53%	2.23%	0.16%	13.04%	34.8%	30.8%	74.42%	110.63%	134.97%
Acquisitions	0	0	963K	0	0	963K	0	0	0	0	0	-12.82M	0	-28.99M	-16.62M	0	439K	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	686K	31K	-963K	0	0	0	0	148K	0	0	0	12.82M	0	28.99M	16.62M	0	-439K	0	0	0
Cash from Financing	19K	6K	5K	0	14K	0	29K	0	79K	0	106K	0	147K	0	144K	0	252K	107K	495K	185K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	19K	6K	5K	14K	14K	0	29K	0	79K	0	106K	0	147K	0	144K	0	252K	107K	495K	185K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	-14K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Change in Cash	1.25M	-94K	-6.08M	8.15M	1.21M	1.19M	-2.17M	3.17M	1.94M	-6.55M	1.65M	-4.09M	-1.39M	5.59M	-1.37M	-12M	-21.4M	16.64M	3.73M	-34.65M
Free Cash Flow	-6.55M	-8.02M	-7.16M	-9.8M	-9.6M	-13.37M	-14.43M	-14.01M	-16.14M	-16.75M	-14.27M	-16.91M	-15.14M	-23.4M	-18.14M	-14.19M	-21.22M	-24.92M	-18.36M	-19.74M
FCF Margin %	-131060%	-30857.69%	-286.24%	-452.01%	-531.98%	-1093.7%	-	-1227.61%	-1266.04%	-317.61%	-683.15%	-669.07%	-1056.8%	-1281.6%	-1285.33%	-671.69%	-1523.04%	-3065.07%	-3613.39%	-2625.27%
FCF Growth %	31.72%	39.97%	50.41%	30.01%	40.55%	20.21%	-1.11%	17.19%	-6.59%	28.42%	21.31%	-19.23%	28.62%	6.09%	1.2%	28.14%	-352.46%	-49.96%	-33.13%	-44.46%
FCF per Share	-3.88	-4.29	-3.83	-5.11	-5.00	-6.97	-7.54	-7.32	-8.47	-8.80	-0.38	-0.45	-0.40	-0.62	-0.48	-0.38	-0.57	-0.67	-0.49	-0.53
FCF Conversion (FCF/Net Income)	0.85x	1.11x	1.08x	1.36x	1.12x	1.21x	0.91x	0.92x	0.76x	1.55x	0.80x	1.03x	0.84x	1.38x	0.90x	0.62x	0.92x	1.03x	0.66x	0.80x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0